Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Barbara Mora & Francesco Passamonti. (2019) Developments in diagnosis and treatment of essential thrombocythemia. Expert Review of Hematology 12:3, pages 159-171.
Read now
Read now
Sarah Chuzi & Brady L. Stein. (2017) Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery. Leukemia & Lymphoma 58:12, pages 2786-2798.
Read now
Read now
Articles from other publishers (10)
Jale Yıldız & Hikmettullah Batgi. (2022) Comparison of Clinical and Hematological Parameters of Janus Kinase 2, Calreticulin or Myeloproliferative Leukemia Virus Oncogene Mutant Essential Thrombocythemia and Triple-Negative Essential Thrombocythemia. Cureus.
Crossref
Crossref
Kuyaş HEKİMLER ÖZTÜRK, Muhammet Yusuf TEPEBAŞI, Halil ÖZBAŞ & Pınar KOŞAR. (2021) POLİSİTEMİA VERA OLGULARINDA JAK2 V617F MUTASYON SIKLIĞI VE LABORATUVAR BULGULARI İLE İLİŞKİSİJAK2 V617F MUTATION FREQUENCY IN POLYCYTHEMIA VERA CASES AND ITS RELATIONSHIP WITH LABORATORY FINDINGS. SDÜ Tıp Fakültesi Dergisi 28:4, pages 573-577.
Crossref
Crossref
Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Mariasanta Napolitano, Melania Carlisi, Marta Mattana, Chiara Russo, Alessandro Di Stefano, Davide Sirocchi & Sergio Siragusa. (2020) The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep. Clinical Medicine Insights: Blood Disorders 13, pages 263485352097821.
Crossref
Crossref
V Accurso, M Santoro, AD Contrino, P Casimiro & S Raso. (2019) Essential thrombocythemia: Biology, clinical features, thrombotic risk, therapeutic options and outcome. Journal of Hematology and Clinical Research 3:1, pages 053-059.
Crossref
Crossref
Youwen Qin, Xiaorui Wang, Chuxian Zhao, Chun Wang & Yining Yang. (2015) The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis. International Journal of Hematology 102:2, pages 170-180.
Crossref
Crossref
Huan-Chau Lin, Caleb Gon-Shen Chen, Ming-Chih Chang, Wei-Ting Wang, Chen Wei Kao, An-Chi Lo, Nai-Wen Su, Yu-Cheng Chang, Yi-Hao Chiang, Kuei-Fang Chou, Po-Nien Liao, Guan-Jhe Cai, Hung-I Cheng, Johnson Lin, Yi-Fang Chang, Ruey-Kuen Hsieh & Ken-Hong Lim. (2013) JAK2 V617F Mutation in Adult Taiwanese Patients with Essential Thrombocythemia: More Prevalent in Old Patients and Correlated with Higher Hemoglobin Level and Higher Leukocyte Count. International Journal of Gerontology 7:1, pages 40-44.
Crossref
Crossref
S.‐J. ZHANG, H.‐X. QIU, J.‐Y. LI, J.‐Y. SHI & W. XU. (2010) The analysis of JAK2 and MPL mutations and JAK2 single nucleotide polymorphisms in MPN patients by MassARRAY assay. International Journal of Laboratory Hematology 32:4, pages 381-386.
Crossref
Crossref
Lisa Pleyer, Daniel Neureiter & Richard Greil. 2010. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Chronic Myeloid Neoplasias and Clonal Overlap Syndromes
51
79
.
Federico Lussana, Sabrina Caberlon, Chiara Pagani, Pieter W. Kamphuisen, Harry R. Büller & Marco Cattaneo. (2009) Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review. Thrombosis Research 124:4, pages 409-417.
Crossref
Crossref
Su-Jiang Zhang, Jian-Yong Li, Jian-Fu Zhang, Jonathan Finn, Hui Lu, Wei Xu, Si-Xuan Qian & Han-Xin Wu. (2009) The decrease of JAK2 V617F allele burden in leukemia transformation of an elderly patient with myelofibrosis. Leukemia Research 33:8, pages e116-e118.
Crossref
Crossref